UBS reduced Element Solutions' price target to $47 citing valuation concerns, though maintaining a Buy rating amidst strong electronics demand. The move highlights valuation scrutiny within the specialty chemicals and electronics sectors, contrasting with positive analyst revisions elsewhere. Despite the Solstice merger termination, upward earnings revisions suggest resilient fundamentals, though near-term valuation pressure persists.
2 articles
UBS lowered Element Solutions' price target to $47 citing valuation concerns despite strong electronics demand, following the termination of its merger with Solstice Advanced Materials.
Monteverde & Associates PC initiated legal inquiries into proposed mergers for Element Solutions, Crinetics Pharmaceuticals, Solstice Advanced Materials, and Patrick Industries. Shareholders are encou
ChemBrief